A New Study Links GLP-1 Drugs to Hair Loss, but the Risk Is Still Low Theres also a chance, according to the researchers, that the drugs themselves might not even be the cause
Key Mechanistic Difference Between Ipamorelin and Tesamoreline Tesamorelin targets the GHRH signalling
Retatrutide and the Future of Cardiometabolic Medicine Retatrutide represents a new era in cardiometabolic disease: one drug, multiple pathways, broad benefits
Second, despite accounting for many relevant covariates in the adjustment and employing IPTW techniques, we may have missed some potentially relevant information and thus we cannot rule out residual confounding
Sublingual troches: Typical dose: 50-200mcg per troche Frequency: 1-2 times daily Administration: Dissolve between cheek and gum for 15-20 minutes Absorption: Bypasses first-pass liver metabolism through oral mucosa Liposomal oral: Typical dose: 100-500mcg Frequency: Once daily Note: Lipid encapsulation protects peptide through digestion Oral forms suit those unwilling to inject who still want systemic rather than purely local effects
Muscle-to-fat ratio is a story